TABLE 3.
Comparisons of data between full ID and limited ID patient groups
Group of patients or differences between groups | No. of patients | Mean length of stay in days (95% CI) or differencea | Mean actual variable cost in dollars (95% CI) or difference | No. of patients receiving antifungal therapy (% [95% CI]) or difference | % Mortality (95% CI) or difference |
---|---|---|---|---|---|
Full ID | 267 | 12.1 (10.9-13.2) | 9,407 (7,870-10,945) | 103 (38.6 [32.8-44.4]) | 18.7 (14.0-23.4) |
Limited ID | 77 | 10.1 (8.1-12.1) | 6,973 (5,042-8,905) | 16 (20.8 [11.7-29.9]) | 14.3 (6.5-22.1) |
Differences between full ID and limited ID groups | −2b | −2,434b | −17.8b | −4.4b | |
Differences between all other patients in the time periods of full ID and limited ID groups | 0.2 | 87 | 0.06 | −0.04 |
CI, confidence interval.
−, decrease in the limited ID group. P values were 0.02 for length of stay, 0.03 for actual variable cost, 0.004 for use of antifungal therapy, and 0.37 for mortality.